Autoimmune disorders of erythropoiesis.
Immune-mediated disorders of erythropoiesis can result in acquired severe anemia, low reticulocyte counts, and bone marrow exhibiting pure red cell aplasia or ineffective erythropoiesis. Erythropoiesis can be suppressed or impaired by humoral or cellular mechanisms. In vitro inhibition of erythroid colony growth by immunoglobulins or lymphocytes can be a strong argument for the immune origin of the disease. Classical etiologies are thymoma and hematologic malignancies such as chronic lymphocytic leukemia (CLL). Clonal proliferation of T cells has been incriminated. Recently, acquired circulating autoantibodies directed against erythropoietin have been detected in a case of pure red cell aplasia. Autoimmune mechanisms have also been detected or suggested in synartesis and in Fas-associated dyserythropoiesis, two distinct syndromes recently described where morphologic abnormalities specific to the erythroid lineage illustrate ineffective erythropoiesis.
Croisille
L
L
Laboratoire d'Hématologie, Centre Hospitalier de Bicêtre, Le Kremlin-Bicêtre, and Laboratoire d'Hématologie, Hopital Hôtel Dieu, Paris, France.
Tchernia
G
G
Casadevall
N
N
D000818:Animals; D001323:Autoantibodies / Q000276:immunology; D001327:Autoimmune Diseases / Q000209:etiology / Q000276:immunology*; D004920:Erythropoiesis / Q000276:immunology*; D006801:Humans; D012010:Red-Cell Aplasia, Pure / Q000150:complications / Q000276:immunology; D019014:fas Receptor / Q000378:metabolism
D001323:Autoantibodies; D019014:fas Receptor